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aBSTRaCT
The effect of different doses of methanol extract of terminalia avicennioides (Combretaceae) on acute 
mucosal damage induced by 0.6 M HCl and on mucus production in the stomach of rats was studied. Animals 
treated with t. avicennioides at a dose of 350 mg/kg showed a significant (P<0.05) reduction of gastric lesions 
produced by HCl, while the reduction in gastric damage was highly significant (P<0.01) at doses of 500 and 
900 mg/kg when all the experiments were compared with rats treated with normal saline (untreated control). 
Similarly, the extract of t. avicennioides at 350, 500 and 900 mg/kg produced a significant (P<0.05) increase 
in mucus production when compared with normal saline (untreated) and cimetidine (treated) control rats. The 
effect of the extract on both gastric damage and mucus production were shown to dose-dependent. This study 
has therefore validated the claim that the plant possesses an ulcer healing effect.
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Introduction
Peptic ulcer disease is a chronic inflammatory disease characterised by ulceration 
in the regions of upper gastrointestinal tract where parietal cells are found and where 
they secrete hydrochloric acid (HCl) and pepsin. The anatomic sites where ulcer occurs 
commonly are stomach and duodenum, causing gastric and duodenal ulcer, respectively 
(RANG et al., 2003). Pathophysiology of ulcer is due to an imbalance between aggressive 
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factors (acid, pepsin, h. pylori and non-steroidal anti-inflammatory agents) and local 
mucosal defensive factors (mucus bicarbonate, blood flow and prostaglandins). Integrity 
of gastro-duodenal mucosa is maintained through a homeostatic balance between these 
aggressive and defensive factors (HOOGERWERF and PASRICHA, 2001). One major cause 
of peptic ulceration in human and in small animals (dogs and cats) is the chronic use of 
non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of mild to moderate 
pain, and also inflammatory conditions (BRUNTON, 1996). The therapeutic and adverse 
effects of NSAIDs have been attributed to the ability of these drugs to inhibit the action 
of cyclooxygenase (COX) (DAVIES and WALLACE, 1997). COX is responsible for 
the synthesis of prostaglandins that normally inhibit acid secretion, as well as having 
a protective effect on the gastric mucosa (RANG et al., 2003). Infection of the stomach 
mucosa with helicobacter pylori - a Gram-negative spiral-shaped bacterium - is 
now generally considered to be a major cause of gastro-duodenal ulcer (RANG et al., 
2003). Several drugs are widely used to prevent or treat gastro-duodenal ulcers; these 
include H2-receptor antagonists (cimetidine), proton pump inhibitors (omeprazole) and 
cytoprotectives (misoprostol) (RASKIN et al., 1995). Antacids, e.g. aluminium hydroxide 
and magnesium hydroxide, are used often to neutralize excess gastric acidity in the 
stomach. Due to problems associated with recurrence after treatment, there is therefore 
the need to seek alternative drug sources against GI ulcers (RANG et al., 2003).
terminalia avicennioides belongs to the family Combretaceae (KEAY et al., 1960). The 
powdered leaves of t. avicennioides are used to treat ringworm infection and other skin 
diseases. The dried powdered root mixed with wasted bulbs of Crinum spp. and made into 
ointment with fresh cow butter is used for the treatment of rheumatic pain and other swollen 
joint conditions (DALZIEL, 1955). Traditionally, the Fulanis (the major cattle rearing 
people in Nigeria) use a decoction from the root of t. avicennioides for the treatment of 
helminthiasis (DALZIEL, 1955; IBRAHIM et al., 1983). The bark of t. avicennioides was 
shown to be active against Vibrio cholera; an aqueous extract administered to cholera 
patients reduced the incidence of diarrhoea by 85-90% (AKINSIDE and OLUKOYO, 1995). 
Similarly, the leaf extract of t. avicennioides demonstrated significant activity against 
salmonella typhi and salmonella paratyphi infection (AKINYEMI et al., 2003) Decoction 
of the bark of t. avicennioides is used to treat gastric and peptic ulcers (S. Garba, Personal 
Communication). The aim of this study is to determine the protection afforded by the 
methanol extract of the root of t. avicennioides in HCl-induced gastric mucosal damage 
in rats. 
Materials and methods
animals. Albino rats (Wistar strains) weighing between 85-187 g were used for all 
experiment in this study. They were purchased from Animal House, Department of Public 
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Health and Preventive Medicine, Ahmadu Bello University, Zaria, Nigeria. Animals were 
allowed to acclimatize for 3 weeks in the laboratory. Wood shavings were used as bedding 
and were changed once throughout the period of the experiment. Rats were fed standard 
diet and tap water was provided ad libitum.
Preparation of plant materials. Fresh leaves, seeds and root of t. avicennioides 
were collected in the wild around Zaria. The plant was identified at the herbarium of 
Department of Biological Sciences, A.B.U., Zaria, by Mr. Musa Mohammed (herbarium 
keeper) where voucher number 402 was deposited. The root was air-dried, made into 
powdered form using a slab mill (Chust, and Merie Ltd, England; Serial No. 49814). Two 
hundred grams (200 g) of powdered root was macerated in a separating funnel using 70% 
methanol. Thereafter, the extract was concentrated in a water bath to a dark brown solid 
residue. The yield of the extract was 22% w/w. 
Phytochemical screening. The extract was evaluated for the presence of flavonoids, 
tannins, alkaloid, saponins and sterols/triterpenes using method described by BRAIN and 
TURNER (1975).
Determination of maximum tolerated doses. Rats were randomly assigned into 5 
groups of 3 animals each. Groups 1, 2, 3 and 4 were treated with 100, 500, 1000 and 1500 
mg/kg of extracts of t. avicennioides, respectively. Group 5 received normal saline and 
served as untreated control.
Gastroprotective studies. Twenty-five rats were randomly allocated into 5 groups 
of 5 animals each. Prior to the experiment, animals were fasted for 24 hours but water 
was provided ad libitum. Animals in group 1 were treated with normal saline at 5 mL/kg 
and served as untreated control, while animals in group 2 were treated with cimetidine 
(15 mg/kg) and served as treated control. Groups 3, 4, and 5 were treated with 350, 500 
and 900 mg/kg of the extract, respectively. All treatments were done intragastrically via 
stomach tube. Prior to treatment all animals were placed under anaesthesia using ketamine 
hydrochloride (11-22 mg/kg). Thirty minutes after pre-treatment with cimetidine, extract 
or normal saline, individual animals were again intubated using stomach tube, and were 
given 0.6 M HCl via the stomach tube (1 mL/rat). The animals were allowed to recover from 
anaesthesia and were sacrificed 2½ h. after treatment with HCl in a chloroform chamber. 
On each animal, a ventral midline incision was made and the stomach exteriorised and 
opened through the greater curvature, rinsed, laid out on a flat surface and examined for 
the presence of mucosal lesions. A 2x hand lens was used to locate and score the lesions 
according to the method of (OHARA et al., 1995). Severity of the gastric mucosal damage 
was graded as follows; grade 0, no lesion; grade 1, haemorrhagic erosion (less than 5); 
grade 2, haemorrhagic erosion (more than 5); grade 3, many small linear ulcers (shorter 
than 2 mm); grade 4, multiple linear ulcers of marked size. The ulcer index for each group 
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was calculated by multiplying the number of rats in each grade by the number of grade 
divided by the number of rats in each group.
Gastric mucus determination. Adherent gastric mucus concentration was determined 
by the method of CORNE et al. (1974). Briefly, the stomachs were removed, opened along 
the greater curvature and rinsed in saline. They were incubated for 2 h. in 20 mL of 0.1% 
w/v alcian blue in 0.16 M sucrose solution buffered with 0.05 M sodium acetate (pH 
5.8). The excess dye was removed by rinsing twice for 15 min. and then 30 min. in 0.25 
M sucrose. The mucus-bound dye was extracted by immersing the gastric tissue in 0.5 
M magnesium chloride, which was intermittently shaken for 1 min. at 30-min. intervals 
for a 2 hr period. The blue extract was centrifuged at 5000 g for 10 min. The clear upper 
aqueous layer was measured spectrophotometrically at 605 nm after preparing a standard 
curve with highly purified pig gastric mucin. The results are expressed as µg/gram of wet 
tissue (YUSUF et al., 2004).
statistical analysis. Data were presented as means ± standard error of mean (SEM). 
Differences between means were analysed by Student’s t test using Microsoft Excel 
computer software. Statistical probability of 5% was used as a criterion for significance. 
Results
Phytochemical screening. Phytochemical test of the extract revealed the presence of 
tannins, alkaloids, saponins, sterol/triterpenes and flavonoids.
Determination of maximum tolerated doses. The extract at doses of 100, 500 and 
1000 mg/kg produced no apparent toxic signs or mortality. However, at 1500 mg/kg, 
depression and hard faeces were observed.
effect on hCl-induced gastric damage. The result is depicted in Fig. 1. The ulcers 
indices in rats treated with cimetidine (15 mg/kg) and t. avicennioides (350 mg/kg) were 
found to be significantly (P<0.05) lower than that of normal saline (control) treated rats. 
In addition, animals that received the t. avicennioides (TA) methanol extract at 500 and 
900 mg/kg showed a significant (P<0.05) lower ulcer indices than those treated with 
normal saline, cimetidine or TA (350 mg/kg).
effect on gastric mucus production. The effect of t. avicennioides methanol extract 
on gastric mucus is depicted in Fig. 2. There was a significant (P<0.05) decrease in the 
concentration of gastric mucus in rats treated with cimetidine (15 mg/kg) when compared 
with the normal saline treated group. Furthermore, animals treated with TA at 350, 500 
and 900 mg/kg showed a significant (P<0.05) increase in mucus production compared to 
NS (5 ml/kg) and CD (15 mg/kg) treated rats (Fig. 2).
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Fig. 1. The effect of t. avicennioides (TA) (350-850 mg/kg) and cimetidine (CD) (15 mg/kg) on 
HCl-induced gastric ulcers in rats. Control group was dosed with normal saline at 5 ml/kg. Values 
are mean ± SEM. **P<0.01 and *P<0.05 show significant difference when compared with normal 
saline treated control group.
Fig. 2. The effect of t. avicennioides (TA) (350-850 mg/kg) and cimetidine (CD) (15 mg/kg) on 
gastric mucus production in rats. Control group was dosed with normal saline at 5 ml/kg. Values 
are mean ± SEM. **P<0.001 and *P<0.05 show significant difference when compared with 
normal saline treated control group.
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Discussion
Ethnomedicines, such as t. avicennioides, are used with apparent success in West 
Africa, particularly among the rural people, to treat various ailments, in part because of 
their rich history and confidence in their use but also because orthodox medicines are 
expensive and beyond the reach of the majority of our communities. Traditional medical 
practices have employed herbal remedies worldwide for the prevention and treatment of 
different diseases. Scientific research and clinical trials have confirmed the efficacy of 
several plants for the treatment and prevention of a number of diseases. Gastroduodenal 
ulcers are among those diseases that are treated using herbal remedies. These were 
demonstrated in researches carried out by some workers (BISHAYEE and CHATTERJEE, 
1994; KANNER and LAPIDOL, 2001; MEYER et al., 2002). The result of this study showed 
that the methanol extract of the root of t. avicennioides significantly (P<0.05) reduced 
gastric damage produced by HCl in rats. The extract produced its gastroprotective effects 
in a dose-dependent manner.
In the present study, the methanol extract of terminalia avicennioides was shown to 
have no apparent toxic effect at a dose of 1000 mg/kg or less. ABDULLAHI et al (2001) 
showed the LD50 of t. avicennioides administered by the intraperitoneal route to be 
875 mg/kg. Agents administered via the oral route may be metabolised and partially or 
completely removed by the liver. Perhaps this explains why t avicennioides at 1000 mg/
kg administered orally did not produce any apparent toxic effect.
Gastric mucus is known to protect the gastric mucosa against damage by HCl 
produced by parietal cells. It consists of viscous, elastic, adherent and transparent gel 
formed by 95% water and 5% glycoproteins that cover the entire gastrointestinal mucosa. 
Moreover, mucus is capable of acting as an antioxidant and thus can reduce mucosal 
damage mediated by oxygen-free radicals (REPETTO and LLEUSY, 2002). The protective 
properties of the mucus barrier depend not only on gel structure but also on the amount or 
thickness of the layer covering the mucosal layer (PENISSI and PIEZZI, 1999). A decrease 
in gastric mucus renders the mucosa susceptible to injuries induced by acid, aspirin or 
cold restraint stress (CROSS et al., 1984). The effect of t. avicennioides in gastric mucus 
production was investigated. The results showed that the extract significantly (P<0.05) 
enhances gastric mucus production when compared with cimetidine and normal saline 
treated rats. The production of gastric mucus by t. avicennioides was also shown to be 
dose-dependent. In a study carried out by HO et al. (1986), cimetidine showed a significant 
suppression of gastric mucus synthesis in rats. The biosynthesis of mucin in rat gastric 
corpus mucosa was enhanced by histamine in a dose-dependent manner (ICHIKAWA et al., 
1998). These findings agreed with the result of this study, where gastric mucus production 
is significantly (P<0.05) lower in rats treated with cimetidine when compared with t. 
avicennioides-treated rats. It is therefore assumed that the gastroprotective effect of t. 
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avicennioides is due to its ability to enhance gastric mucus production, which protects 
the gastric mucosal membrane against aggressive factors such as HCl, pepsin and bile 
pigments. This action is similar to the action of prostaglandin analogue (misoprostol), 
which produces its cytoprotective effect mainly by causing enhanced gastric mucus 
production (WANG et al., 1989). 
Reactive oxygen species generated by the metabolism of arachidonic acid in platelets, 
macrophages and smooth muscle cells may contribute to gastric mucosal damage. 
Free radical scavengers, therefore, could prove useful in protecting the gastric mucosa 
from oxidative damage or by accelerating healing of gastric ulcers (HAHN et al., 1997). 
Antioxidants act as radical scavengers, inhibit lipid peroxidation and other free radical-
mediated processes and therefore they protect the human body from several diseases 
attributed to the reaction of radicals. Plant chemical substances such as flavonoids, 
tannins, have been shown to scavenge free radicals and therefore are viewed as promising 
therapeutic drugs for free radicals pathologies (CZINNER et al., 2001; SATOSHI et al., 2003). 
Phytochemical test revealed the presence of flavonoids and tannins in the extract of t. 
avicennioides. In addition, tannins extracted from the plant syzygium cumini exhibited 
a gastroprotective effect and significantly lowered free radical concentrations in the 
stomach of rats (REBECCA and CAMILO, 2004). These findings might well suggest that 
tannins present in t. avicennioides have gastroprotective and anti-ulcerogenic effects. 
t. avicennioides possessed antibacterial activity, as revealed through its effect on 
Vibrio cholera (AKINSIDE and OLUKOYO, 1995). h. pylori (a bacterium) infects the 
stomach of more than 50% people worldwide and is responsible for most peptic ulcer 
diseases, gastritis and gastric malignancies of ulcer (FORMAN et al., 1991; BLASER, 1992; 
PARSONNET et al., 1994). Eradication of h. pylori infection is strongly recommended 
in duodenal and gastric ulcers, whether they are active or not. Cure of the infection not 
only promotes peptic ulcer healing but also reduces ulcer relapse (WEI-HAO et al., 2005). 
Antimicrobial agents (clarithromycin, amoxicillin or metronidazole) have been shown to 
be effective in the treatment of gastroduodenal ulcers. It may therefore be reasonable to 
assume that the ulcer-healing effect of t. avicennioides is partly due to its antibacterial 
action, particularly against h. pylori infection. 
Conclusion
The study showed that t. avicennioides affords a gastroprotective effect against 
HCl-induced gastric damage in normal rats. Furthermore, the plant also enhances gastric 
mucus production in rats. This action perhaps explains its mechanism of action. Further 
studies to elucidate the active compounds contained in the extract and to evaluate the 
efficacy of the plant against h. pylori infection are required. Moreover, there is a need 
Vet. arhiv 77 (4), 345-354, 2007
M. M. Suleiman et al.: Gastroprotective effect of the crude methanol extract of terminalia avicennioides in rats
352
to conduct detailed toxicity studies, using the plant on both laboratory and target animal 
species, to justify clinical investigation in other species of animals and in humans.
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Sažetak
Istražen je učinak različitih doza metanolskoga iscrpka biljke terminalia avicennioides (Combretaceae) na 
akutno oštećenje želučane sluznice i proizvodnju želučane sluzi u štakora. Akutno oštećenje želučane sluznice 
bilo je izazvano 0,6 M otopinom HCl-a. Životinje obrađene iscrpkom t. avicennioides u dozi od 350 mg/
kg pokazale su statistički značajno (P<0,05) slabije oštećenje želučane sluznice. U usporedbi s kontrolnom 
skupinom (štakori koji su dobivali fiziološku otopinu), isti učinak bio je statistički visoko značajan (P<0,01) 
pri dozama od 500 i 900 mg/kg. Također, iscrpak terminalia avicennioides u dozama od 350, 500 i 900 mg/
kg potaknuo je značajan (P<0,05) porast proizvodnje želučane sluzi u usporedbi s kontrolnom i skupinom 
obrađivanom cimetidinom. Učinci iscrpka iz terminalia avicennioides na oštećenja želuca i proizvodnju sluzi 
ovise o dozi. Rezultati istraživanja potvrdili su tvrdnju da biljka ima učinke koji pospješuju liječenje želučanoga 
vrijeda. 
ključne riječi: terminalia avicennioides, želučani vrijed, zaštita želuca
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